RU93000552A - DRUGS FUGENTIN - Google Patents
DRUGS FUGENTINInfo
- Publication number
- RU93000552A RU93000552A RU93000552/14A RU93000552A RU93000552A RU 93000552 A RU93000552 A RU 93000552A RU 93000552/14 A RU93000552/14 A RU 93000552/14A RU 93000552 A RU93000552 A RU 93000552A RU 93000552 A RU93000552 A RU 93000552A
- Authority
- RU
- Russia
- Prior art keywords
- nose
- fugentin
- ear
- drug
- drugs
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims 6
- 229940079593 drugs Drugs 0.000 title claims 5
- 210000001331 Nose Anatomy 0.000 claims 3
- 229940064005 Antibiotic throat preparations Drugs 0.000 claims 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 claims 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 claims 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 claims 1
- 229940047652 Ear Drops Drugs 0.000 claims 1
- 229960004675 Fusidic Acid Drugs 0.000 claims 1
- IECPWNUMDGFDKC-MZJAQBGESA-N Fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 claims 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 claims 1
- 229940100662 Nasal Drops Drugs 0.000 claims 1
- 206010058046 Post procedural complication Diseases 0.000 claims 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000003115 biocidal Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 229960002518 gentamicin Drugs 0.000 claims 1
- 229940079866 intestinal antibiotics Drugs 0.000 claims 1
- 230000003000 nontoxic Effects 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 231100000486 side effect Toxicity 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU93000552A RU2077327C1 (en) | 1993-01-05 | 1993-01-05 | Medicinal agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU93000552A RU2077327C1 (en) | 1993-01-05 | 1993-01-05 | Medicinal agent |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93000552A true RU93000552A (en) | 1995-05-10 |
RU2077327C1 RU2077327C1 (en) | 1997-04-20 |
Family
ID=20135270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93000552A RU2077327C1 (en) | 1993-01-05 | 1993-01-05 | Medicinal agent |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2077327C1 (en) |
-
1993
- 1993-01-05 RU RU93000552A patent/RU2077327C1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2116559A1 (en) | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases | |
HUT51136A (en) | Process for producing pharmaceutical compositions for treating schisophreny, containing l-deprenil as active component | |
CA2118121A1 (en) | Methods and compositions for the treatment of diseases with interferon while reducing side effects | |
AU1358695A (en) | Nasal administration | |
DE69230046D1 (en) | 2-bromomelatonin for the treatment of sleep disorders | |
GEP20002298B (en) | Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment | |
BR9609063A (en) | Dinucleotides useful for the treatment of lung diseases | |
DE69815122D1 (en) | SACCHARID-CONTAINING PREPARATIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES | |
BR9507506A (en) | Process to exterminate a cell process for cancer treatment composition and therapeutic kit | |
BRPI9509286B8 (en) | drug and / or nutritional microcapsules for administration per se. | |
CA2289717A1 (en) | Novel therapy for constipation | |
CA2215692A1 (en) | Method of modulating microcirculation | |
ATE99172T1 (en) | USE OF ACETYL-L-CARNITINE IN TREATMENT OF CATARACT, AND PHARMACEUTICAL COMPOSITIONS FOR SUCH TREATMENT. | |
KR890003387A (en) | Double-stranded RMAs Composition with Local Activity | |
DE69210802D1 (en) | PHARMACEUTICAL AEROSOL PREPARATION AND THEIR USE FOR TREATING AND PROPHYLAXIS OF VIRAL DISEASES | |
AU7425391A (en) | Use of n-alkylated 1, 4-dihydropyridinedicarboxylic acid esters as medicaments, new compounds and processes for their preparation | |
CA2143610A1 (en) | Use of norastemizole for the treatment of allergic disorders | |
DK0668077T3 (en) | Products containing G-CSF and TNF-binding protein | |
CA2020346A1 (en) | Antibiotic ge 2270 factors a1, a2, a3 and h | |
CA2037779A1 (en) | Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t | |
RU93000552A (en) | DRUGS FUGENTIN | |
KR900701278A (en) | Bile acids for the treatment of viral infections | |
EP0228239A3 (en) | Preparation of a medicament for arthritis and rheumatism | |
MY111746A (en) | Therapeutic nucleosides. | |
KR960003718A (en) | Use of Ifenprodil and its Diastereomers for the Preparation of Medicines Useful for the Treatment of Peripheral and Central Neurodegenerative Diseases |